Patents by Inventor Julius Diamond

Julius Diamond has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Thermochromic game piece
    Patent number: 6307664
    Abstract: A thermochromic game or prize or message indicator includes a typical thermochromic or thermally sensitive battery testers coupled to a first conductive substrate with a second thermally responsive game piece or prize or message indicator of the present invention combines a typical thermochromic or thermally sensitive battery tester coupled to the conductive substrate with an extension of the conductive substrate. The thermochromic game or prize of message indicator can be used to display a verbal message or icon for conveying whether a prize has been won. Additionally, the thermochromic game or prize or message indicator can be used to display any desired verbal message or icon.
    Type: Grant
    Filed: February 14, 2000
    Date of Patent: October 23, 2001
    Inventors: Jack Brass, Julius Diamond
  • Antiarrhythmic imidazoles
    Patent number: 4689341
    Abstract: The imidazolium salts described are useful as antiarrhythmic agents. A method of treating arrhythmia by increasing the refractoriness of cardiac tissue is provided as well as pharmaceutical formulations containing such imidazolium salts.
    Type: Grant
    Filed: July 3, 1986
    Date of Patent: August 25, 1987
    Assignee: Schering A.G.
    Inventors: Julius Diamond, William C. Lumma, Jr., Thomas K. Morgan, Jr., Ronald A. Wohl
  • Dobutamine tri-isobutyric acid ester and the use thereof as a cardiotonic agent
    Patent number: 4663351
    Abstract: A novel, orally administrable pro-drug form of dobutamine of the formula ##STR1## or a pharmaceutically acceptable acid addition salt thereof.
    Type: Grant
    Filed: August 23, 1985
    Date of Patent: May 5, 1987
    Assignee: Berlex Laboratories, Inc.
    Inventor: Julius Diamond
  • Antiarrhythmic imidazoliums
    Patent number: 4613609
    Abstract: The imidazolium salts described are useful as antiarrhythmic agents. A method of treating arrhythmia by increasing the refractoriness of cardiac tissue is provided as well as pharmaceutical formulations containing such imidazolium salts.
    Type: Grant
    Filed: November 27, 1984
    Date of Patent: September 23, 1986
    Assignee: Schering A. G.
    Inventors: Julius Diamond, William C. Lumma, Jr., Thomas K. Morgan, Jr., Ronald A. Wohl
  • Antiarrhythmic imidazoliums
    Patent number: 4581370
    Abstract: The imidazolium salts described are useful as antiarrhythmic agents. A method of treating arrhythmia by increasing the refractoriness of cardiac tissue is provided as well as pharmaceutical formulations containing such imidazolium salts.
    Type: Grant
    Filed: July 12, 1983
    Date of Patent: April 8, 1986
    Assignee: Schering A.G.
    Inventors: Julius Diamond, William C. Lumma, Jr., Thomas K. Morgan, Jr., Ronald A. Wohl
  • N-[2-hydroxy-2-(3-hydroxyphenyl)ethyl]-1H-benzimidazole-1-butanamine and use thereof as a cardiotonic agent
    Patent number: 4517310
    Abstract: The compound N-[2-hydroxy-2-(3-hydroxyphenyl)ethyl]-1H-benzimidazole-1-butanamine and methods for its manufacture and use are described herein. The compound is a cardiotonic agent useful primarily in the treatment of congestive heart failure.
    Type: Grant
    Filed: July 28, 1981
    Date of Patent: May 14, 1985
    Assignee: Berlex Laboratories, Inc.
    Inventors: Julius Diamond, Ronald A. Wohl
  • Amidinoureas
    Patent number: 4515718
    Abstract: A novel method of treating gastrointestinal, spasmolytic and ulcerogenic disorders by the administration of amidinoureas is disclosed.
    Type: Grant
    Filed: September 30, 1982
    Date of Patent: May 7, 1985
    Assignee: William H. Rorer, Inc.
    Inventors: Julius Diamond, George H. Douglas
  • Amidinoureas
    Patent number: 4488993
    Abstract: Novel phenylamidinourea compounds and processes for their preparation are described. These compounds have an effective degree of anti-hypertensive properties and exert activities on the cardiovascular system. A method for the treatment of hypertensive disorders is also described.
    Type: Grant
    Filed: October 25, 1982
    Date of Patent: December 18, 1984
    Assignee: William H. Rorer, Inc.
    Inventors: George H. Douglas, Julius Diamond
  • Systemic treatment of psoriasis using certain salicylates
    Patent number: 4483854
    Abstract: Psoriasis is systemically treated by the administration of a salicylate which is capable of inhibiting the endogenous lipoxygenase present in psoriatic plaque fluid without the inhibition of the cyclooxygenase enzyme.
    Type: Grant
    Filed: April 12, 1983
    Date of Patent: November 20, 1984
    Assignee: Key Pharmaceuticals, Inc.
    Inventor: Julius Diamond
  • Amidinoureas
    Patent number: 4440765
    Abstract: A novel method of treating gastrointestinal, spasmolytic and ulcerogenic disorders by the administration of amidinoureas is disclosed.
    Type: Grant
    Filed: December 8, 1981
    Date of Patent: April 3, 1984
    Assignee: William H. Rorer, Inc.
    Inventors: Julius Diamond, George H. Douglas
  • Treating cardiovascular diseases with N-(3-phenoxy-2-hydroxypropyl)benzimidazole-1-alkanamines
    Patent number: 4434174
    Abstract: 3-Phenoxy-2-hydroxypropylamines having an N-benzimidazolyalkyl substituent and similar compounds are described herein. They are obtained by the reaction of the appropriate imidazole-1-alkanamine with an epoxide, and they are useful primarily as .beta..sub.1 -agonists/.beta.-sympathomimetic agents.
    Type: Grant
    Filed: March 2, 1982
    Date of Patent: February 28, 1984
    Assignee: Berlex Laboratories, Inc.
    Inventors: Julius Diamond, Ronald A. Wohl
  • Amidinothioureas
    Patent number: 4418209
    Abstract: This invention describes a new class of 1-amidino-3-phenylthiourea and N'-phenylamidinothiourea compounds wherein the phenyl group is ortho substituted, and processes for their preparation. The phenylamidinothiourea compounds may be incorporated into pharmaceutical preparations which are useful for producing anti-ulcerogenic, antisecretory, antispasmodic, antihypertensive, anti-arrhythmic, anesthetic, antidiarrheal and antiparasitic action.
    Type: Grant
    Filed: December 21, 1981
    Date of Patent: November 29, 1983
    Assignee: William H. Rorer, Inc.
    Inventors: George H. Douglas, Julius Diamond, William L. Studt, Stuart A. Dodson
  • Method of use of antiarrhythmic 1-arylcarbamoylalkyl imidazole derivatives, composition
    Patent number: 4415587
    Abstract: Novel 1,2-disubstituted imidazol(in)es are described herein. The compounds are generally produced by reacting a haloacylanilide with an excess of 2-substituted-imidazol(in)e. The compounds are antiarrhythmic agents.
    Type: Grant
    Filed: August 12, 1982
    Date of Patent: November 15, 1983
    Assignee: Berlex Laboratories, Inc.
    Inventors: Julius Diamond, Thomas K. Morgan, Jr., Ronald A. Wohl
  • Ethynylbenzene compounds and derivatives thereof
    Patent number: 4365093
    Abstract: Novel ethynylbenzene compounds and their derivatives which are useful for the treatment for the relief of inflammation, pain and fever.
    Type: Grant
    Filed: November 23, 1976
    Date of Patent: December 21, 1982
    Assignee: William H. Rorer, Inc.
    Inventor: Julius Diamond
  • N-(3-Phenoxy-2-hydroxypropyl)benzimidazole-1-alkanamines
    Patent number: 4363808
    Abstract: 3-Phenoxy-2-hydroxypropylamines having an N-benzimidazolyalkyl substituent and similar compounds are described herein. They are obtained by the reaction of the appropriate imidazole-1-alkanamine with an epoxide, and they are useful primarily as .beta.-adrenergic blocking agents.
    Type: Grant
    Filed: May 7, 1981
    Date of Patent: December 14, 1982
    Assignee: Berlex Laboratories, Inc.
    Inventors: Julius Diamond, Ronald A. Wohl
  • Antiarrythmic 1-arylcarbamoylalkyl-2-imidazoline derivatives, composition and method of use
    Patent number: 4353921
    Abstract: Novel 1,2-disubstituted imidazol(in)es are described herein. The compounds are generally produced by reacting a haloacylanilide with an excess of 2-substituted-imidazol(in)e. The compounds are antiarrhythmic agents.
    Type: Grant
    Filed: June 19, 1981
    Date of Patent: October 12, 1982
    Assignee: Berlex Laboratories, Inc.
    Inventors: Julius Diamond, Thomas K. Morgan, Jr., Ronald A. Wohl
  • Amidinoureas
    Patent number: 4353842
    Abstract: A novel method of treating gastrointestinal, spasmolytic and ulcerogenic disorders by the administration of amidinoureas is disclosed.
    Type: Grant
    Filed: February 5, 1980
    Date of Patent: October 12, 1982
    Assignee: William H. Rorer, Inc.
    Inventors: Julius Diamond, George H. Douglas
  • Amidinoureas
    Patent number: 4326075
    Abstract: A new class of chemical compounds and their process of preparation is described. These compounds have valuable properties as anti-diarrheal agents.
    Type: Grant
    Filed: February 5, 1980
    Date of Patent: April 20, 1982
    Assignee: William H. Rorer, Inc.
    Inventors: Julius Diamond, George H. Douglas
  • Amidinoureas
    Patent number: 4326074
    Abstract: A new class of chemical compounds and their process of preparation is described. These compounds have valuable properties as anti-diarrheal agents.
    Type: Grant
    Filed: December 18, 1979
    Date of Patent: April 20, 1982
    Assignee: William H. Rorer, Inc.
    Inventors: Julius Diamond, George H. Douglas
  • Amidinoureas
    Patent number: 4304786
    Abstract: A novel method of treating gastrointestinal, spasmolytic and ulcerogenic disorders by the administration of amidinoureas is disclosed.
    Type: Grant
    Filed: July 23, 1979
    Date of Patent: December 8, 1981
    Assignee: William H. Rorer, Inc.
    Inventors: Julius Diamond, George H. Douglas